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Background: This follow-up study aims to determine the physical parameters which govern the 
differential radiosensitization capacity of two tumor cell lines and one immortalized normal cell 
line to 1.9 nm gold nanoparticles. In addition to comparing the uptake potential, localization, and 
cytotoxicity of 1.9 nm gold nanoparticles, the current study also draws on comparisons between 
nanoparticle size and total nanoparticle uptake based on previously published data.
Methods: We quantified gold nanoparticle uptake using atomic emission spectroscopy and 
imaged intracellular localization by transmission electron microscopy. Cell growth delay 
and clonogenic assays were used to determine cytotoxicity and radiosensitization potential, 
respectively. Mechanistic data were obtained by Western blot, flow cytometry, and assays for 
reactive oxygen species.
Results: Gold nanoparticle uptake was preferentially observed in tumor cells, resulting in an 
increased expression of cleaved caspase proteins and an accumulation of cells in sub G
1
 phase. 
Despite this, gold nanoparticle cytotoxicity remained low, with immortalized normal cells 
exhibiting an LD
50
 concentration approximately 14 times higher than tumor cells. The surviving 
fraction for gold nanoparticle-treated cells at 3 Gy compared with that of untreated control cells 
indicated a strong dependence on cell type in respect to radiosensitization potential.
Conclusion: Gold nanoparticles were most avidly endocytosed and localized within cytoplasmic 
vesicles during the first 6 hours of exposure. The lack of significant cytotoxicity in the absence 
of radiation, and the generation of gold nanoparticle-induced reactive oxygen species provide 
a potential mechanism for previously reported radiosensitization at megavoltage energies.
Keywords: endocytosis, proliferation, reactive oxygen species, transmission electron microscopy
Introduction
The field of nanomedicine covers a disparate array of research, with applications 
ranging from the use of quantum dots for enhanced in vivo imaging to the use of gold 
nanowires for highly targeted payload delivery at the subcellular level.1,2
Few nanostructures have received as much attention as gold nanoparticles, due to the 
chemically inert nature of gold and the relative ease with which the surface chemistry 
can be manipulated for downstream applications.3–6 Furthermore, gold nanoparticles 
have been investigated in various contexts in relation to cancer diagnosis and treatment, 
including as a delivery vehicle for several chemotherapeutic agents, as a contrast agent 
for enhanced imaging, and for thermal ablation therapy.7–11
Utilizing the differential absorption coefficient of a high atomic number (Z)  material, 
such as gold, compared with soft tissue has shown potential as a radiosensitizing 
strategy through increased local dose deposition as a result of the generation of 
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secondary electron species.12–14 A tissue modeling study 
using gold foil reported a dose enhancement factor of 50 
due to the production of secondary electrons generated from 
low-energy photon irradiation.15 Subsequent progression to 
produce smaller particles, thereby increasing the gold sur-
face area to volume ratio, resulted in the production of gold 
particles in the nanometer range. Hainfeld et al6 detailed the 
first study using 1.9 nm gold nanoparticles as radiosensitizers. 
The gold nanoparticles were administered by tail vein injec-
tion and resulted in a 66% increase in the one-year survival 
of mice bearing EMT-6 mammary tumors when pretreated 
with a single intravenous dose of gold nanoparticles and 
irradiated with 250 kVp x-rays, compared with radiotherapy 
alone. Furthermore, the effects occurred in a dose-dependent 
manner, with no animals exhibiting significant gold nano-
particle-induced cytotoxicity.6 More recently, interest has 
shifted towards the dependence of radiosensitization on the 
energy of the radiation source, with particular emphasis on 
clinically relevant energies. Corroborating both the modeled 
predictions and the findings of Chithrani et al,16 we observed 
a greater radiosensitization potential for cells irradiated with 
lower energy beams, achieving sensitizer enhancement ratios 
of 1.41 and 1.29 for 160 kVp and 6 MV photon sources, 
respectively.16,17 However, discrepancies between the size 
of the modeled enhancement (10–2000-fold, dependent 
on beam energy) and the observed findings suggest a more 
complex role for various biological interactions, which 
remains poorly understood.18 To provide an insight into the 
biological processes governing radiosensitization, numerous 
variables, including nanoparticle size, shape, and charge, 
have been investigated to determine their impact on nanopar-
ticle uptake, intracellular distribution, and radiosensitization 
potential. Chithrani et al19 demonstrated the contribution of 
nanoparticle size to gold nanoparticle uptake by reporting a 
three-fold preferential uptake of 50 nm gold nanoparticles 
compared with 100 nm gold nanoparticles over the same time 
period. A shift in the absorption spectra following incubation 
of the gold nanoparticles in culture medium containing 10% 
serum indicated binding of serum protein to the surface of 
the nanoparticles. The nonspecific binding of serum proteins 
resulted in surface modification, increasing intracellular 
uptake by receptor-mediated endocytosis.19,20
Uncertainty remains as to whether gold nanoparticles 
induce a cytotoxic response, with some authors attribut-
ing cytotoxicity to individual preparations or nanoparticle 
size, while others conclude that gold nanoparticles do not 
induce any immunogenic or cytotoxic effects.21–24 A recent 
study investigating 16 nm gold nanoparticle stability and 
 cytotoxicity in K562 human erythroleukemia cells following 
gamma irradiation reported minimal cytotoxicity (,10%) at 
low gold nanoparticle concentrations (,100 µg/mL), increas-
ing significantly to 58% at the highest gold nanoparticle 
concentration, demonstrating the dose-dependent nature of 
gold nanoparticle cytotoxicity.25
In this study, we aimed to investigate in detail the physical 
parameters contributing to radiosensitization. These include 
precise measurement of the uptake potential affecting dif-
ferent cell types and the intracellular distribution of gold 
nanoparticles, because localization near to critical sites such 
as DNA would significantly modify the sensitivity to radia-
tion treatment. Furthermore, we investigated the impact of 
1.9 nm gold nanoparticles on functional outputs, including 
cytotoxicity measured by changes in proliferative index, 
3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT, Sigma, St Louis, MO) and clonogenic assays. The 
colony-forming assay was also used to determine the extent 
to which 1.9 nm gold nanoparticle treatments could sensitize 
cell line models to a single 3 Gy x-ray dose. Finally, we inves-
tigated if 1.9 nm gold nanoparticles could induce production 
of reactive oxygen species, thereby potentially providing a 
biological mechanism for gold nanoparticle-induced cell death 
and reported radiosensitization at MV photon energies.17
Materials and methods
Cell culture
Human DU145 prostate cancer cells, MDA-MB-231 breast 
cancer cells, and L132 lung epithelial cells were cultured in 
Roswell Park Memorial Institute (RPMI) 1640, Dulbecco’s 
modified Eagle’s medium, and Minimum Essential Medium, 
respectively. All cells were purchased from the American 
Type Culture Collection. All media were supplemented with 
10% fetal bovine serum and 1% penicillin-streptomycin 
(Invitrogen, Carlsbad, CA). All cells were maintained 
in monolayers in a tissue culture incubator at 37°C with 
5% CO
2
/95% air and subcultured every 3–4 days to maintain 
exponential growth.
1.9 nm gold nanoparticles
1.9 nm spherical gold nanoparticles (Aurovist™) used in 
previous radiation studies, were purchased from Nanoprobes 
Inc (Yaphank, NY).6,7,26,27 Gold nanoparticles were suspended 
in molecular grade sterile water (Sigma), filtered through a 
0.2 µm filter, and stored at -20°C as per the manufacturer’s 
instructions at a concentration of 2.4 mM (10% by mass). 
This stock suspension was diluted appropriately to the 
required concentration in culture medium immediately prior 
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to use. Gold concentrations were confirmed using inductively 
coupled plasma atomic emission spectroscopy (ICP-AES).
Gold nanoparticle characterization
A 2 µL aliquot of the gold nanoparticle suspension was 
pipetted onto a mesh formvar-carbon coated copper trans-
mission electron microscopy (TEM) grid (Polysciences 
Inc,  Warrington, PA) and allowed to air-dry. Samples were 
imaged using a field emission TEM (Technai F20), an 
 established method for gold nanoparticle size quantification.21 
Gold nanoparticle size was determined using open-source 
image analysis software (Image J). A minimum of 
400 nanoparticles were analyzed.
Inductively coupled plasma-atomic 
emission spectroscopy
First, 7.5 × 104 cells were plated for 24 hours, then exposed 
to 1.9 nm gold nanoparticles for 1 –24 hours, washed three 
times in phosphate-buffered saline, trypsinized, counted, 
and digested in 0.5 mL of aqua regia (one part 100% nitric 
acid to three parts 100% hydrochloric acid). Each sample 
volume was made up to 5 mL with distilled water, and the 
gold content was determined using a Perkin Elmer Optima 
4300 DV ICP-AES, which measures absolute quantification 
of elemental gold with parts per billion sensitivity.
Calculating the number  
of gold nanoparticles/cell
The amount of gold per cell was calculated from the total gold 
content per sample determined by ICP-AES, and the number 
of cells in each sample counted with a Z1 Coulter particle 
counter (Beckman Coulter Inc, Fullerton, CA). A gold atom 
has a radius of 0.14 nm. The length (L) and volume (F) of a 
gold unit cell can thus be calculated as:
 2L2 = (4r)2
 
L r= = =8 2r 407 pm ( 0.14 nm)
 Volume of gold cell = L3 = 6.74 × 107 pm3 or 67.3 Å3
Gu et al28 calculated the number of gold atoms per nano-
particle using the following formula:
  n
D
F
=




4
3
4
3
π 2
×
where n = number of gold nanoparticles, D = gold nanopar-
ticle diameter, and F = volume of a gold cell.28
Therefore, a 1.9 nm gold nanoparticle is calculated to 
contain about 200 gold atoms.
The volume of a typical cell was calculated assuming a 
spherical cell to allow an approximate estimation of intracel-
lular gold nanoparticle concentration. The typical diameter 
of an MDA-MB-231 cell was estimated (n = 20) using TEM 
at 13.5 µm. The volume is therefore:
  
V r= 4
3
3π
where V is the volume of the cell and r is the radius (6.75 µm). 
The volume is therefore 1288.3 µm3.
The concentration C is calculated by:
  
C
m
V
=
where m = mass of gold/cell.
Confocal microscopy of immunogold
Alexa Fluor® 488 Fluoronanogold™ was purchased from 
Nanoprobes Inc. This product consists of 1.4 nm gold 
nanoparticles conjugated via a hinge thiol to Alexa Fluor 
488 (Molecular Probes, Eugene, OR) enabling visualization 
of gold nanoparticle conjugates using confocal microscopy. 
Then 1 × 104 cells were plated in 4-well Labtek chamber slides 
(Nunc, Waltham, MA) and allowed to adhere for 24 hours. 
The medium was removed, cells washed with phosphate-
buffered saline, and fresh medium was added containing Flu-
oronanogold 8 µg/mL for 1–24 hours. The cell medium and 
gold nanoparticles were removed and the cells were washed 
three times in chilled phosphate-buffered saline. Ice-cold 50% 
methanol to 50% acetone was added for 8 minutes at 4°C to 
fix the cells, which were then mounted with Vectashield and 
4,6-diamidino-2-phenylindole (DAPI, Vector Laboratories, 
Burlingame, CA). Images were acquired using a Leica SP5 
confocal microscope with a FITC filter exciting at 488 nm and 
emitting at 514 nm and a ultraviolet filter exciting at 370 nm 
and emitting at 440 nm wavelengths for DAPI.
TEM and energy dispersive x-ray 
spectroscopy
First, 1.5 × 105 cells were plated for 24 hours, and then 
exposed to 1.9 nm gold nanoparticles for a further 24 hours. 
Cells were washed twice in phosphate-buffered saline, 
trypsinized, pelleted, and fixed in 4% glutaraldehyde in 
0.1 M sodium cacodylate for 4 hours. Cells were post-fixed in 
1% osmium tetroxide in sodium cacodylate for one hour and 
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washed in 0.1 M sodium cacodylate for 2 hours. Cell  pellets 
were then dehydrated in a graded series of ethanol (30%, 
60%, 70%, 90%, and 100%), exposed to propylene oxide for 
10 minutes, infiltrated with 1:1 ratio of propylene oxide and 
resin for one hour, and embedded in agar resin overnight. The 
resin was allowed to polymerize at 60°C for 48 hours, cooled 
for 12 hours, and sectioned at 60–70 nm thickness using a 
Reichert Ultracut E ultramicrotome.  Sections were placed 
on mesh copper support grids, stained with uranyl acetate 
for 12 minutes, lead citrate for 10 minutes, and imaged with 
a Phillips CM 100 TEM (Eindhoven, The Netherlands) at 
100 kV for lower resolution imaging and an FEI Technai F20 
TEM for higher resolution imaging. To confirm the presence 
of gold, the FEI Technai F20 TEM was used in scanning TEM 
mode for energy dispersive x-ray spectroscopy.
Cell growth assay
Initially, 1 × 104 cells were plated for 24 hours, and then 
treated with 0 µM, 2.4 µM, or 12 µM (0 µg/mL, 100 µg/mL, 
or 500 µg/mL, respectively) 1.9 nm gold nanoparticles for 
24 hours, washed twice in phosphate-buffered saline, and 
incubated in fresh culture medium. Cell numbers in the 
control and gold nanoparticle exposed samples were counted 
at hours 0, 24, 48, and 72 using a Z1 counter (Beckman 
Coulter Inc). Results were fitted to an exponential fit using 
Prism 5.0 (GraphPad Software, San Diego, CA).
MTT cell viability assay
First, 5.0 × 103 MDA-MB-231, DU145, or L132 cells were 
plated in each well of a 96-well plate and incubated for 
24 hours to adhere. The culture medium was replaced with 
fresh medium containing various concentrations of gold 
nanoparticles ranging from 10 µg/mL to a maximum of 
2 mg/mL and incubated for a further 24 hours. Cells were 
then exposed to 30 µL of MTT and incubated for a further 
4 hours, after which the medium with MTT was removed, 
the cells were washed once with phosphate-buffered saline, 
and then lysed with 170 µL dimethyl sulfoxide. Plates were 
read using a GENios colorimetric plate reader at 540 nm with 
results plotted relative to unexposed control cells using Prism 
5.0 (GraphPad Software, San Diego, CA). Statistical analysis 
was performed using the Student’s t-test (n = 4).
Gold nanoparticles and radiation
A total of 7.5 × 104 cells were plated in 35 mm2 dishes 
containing culture medium supplemented with fetal 
bovine serum and 1% penicillin-streptomycin for 24 hours. 
The medium was removed, and cells were exposed to 
fresh medium  containing 1.9 nm gold nanoparticles for 
24 hours, then irradiated with 3 Gy x-rays. After irradia-
tion, cells were washed twice in phosphate-buffered saline, 
trypsinized, diluted four-fold to allow sufficient plating 
volume, vortexed at 1800 rpm for 10 seconds to achieve a 
single cell suspension, counted, and replated for survival 
analysis using the clonogenic assay technique described by 
Puck and Marcus.29 Colonies were stained with 0.4% crystal 
violet and counted using a Colcount colony counter (Oxford 
Optronix, Abingdon, UK). Plating efficiency was calculated 
as the ratio of colonies to cells seeded. The surviving frac-
tions were calculated as the plating efficiency of the treated 
group divided by the plating efficiency of the untreated 
control cells. The statistical analysis was performed using 
the Student’s t-test (n = 4).
Western blotting
First, 7.5 × 104 cells were plated in 35 mm2 dishes in culture 
medium supplemented with fetal bovine serum and 1% 
penicillin-streptomycin for 24 hours. Fresh medium contain-
ing 12 µM gold nanoparticles was added for various time 
points up to 48 hours. Whole cell extracts were collected by 
scraping in 250 µL of Laemmli buffer (Sigma) and stored 
at -20°C. Before use, cell lysates were heated to 90°C for 
10 minutes to denature proteins. The Novex Mini-cell system 
(Invitrogen) was used for protein separation and transfer. 
A 10% NuPAGE Bis-Tris gel (Invitrogen) was submerged in 
1 × 3-(N-morpholino)propanesulfonic acid (MOPS) running 
buffer (Invitrogen). A 20 µL sample was loaded with 10 µL 
SeeBlue Plus2 prestained protein standard (Invitrogen), and 
electrophoresed at 200 V for 2 hours. Proteins were trans-
ferred to Hybond-C nitrocellulose membrane (GE Healthcare 
Bio-Sciences UK Ltd, Little Chalfont, UK), immersed in 
1 × transfer buffer (Invitrogen) and transferred at 25 V for 
1.5 hours. Membranes were blocked in 1% blocking solution 
for 20 minutes and incubated overnight in 1:1000 primary 
antibody and 1% blocking solution at 4°C. Human-specific 
primary antibodies used were poly(ADP-ribose)polymerase 
(PARP), cleaved PARP, caspase-9, cleaved caspase-9 and 
β-actin (Cell Signaling 9542, 9541, 9502, 9501, and Sigma 
A3583, respectively).
Membranes were washed three times for 5 minutes in 
phosphate-buffered saline and 0.1% Tween-20, followed 
by a final 5-minute wash in phosphate-buffered saline, and 
then incubated in 1:5000 antirabbit secondary antibody 
(GE Healthcare Bio-Sciences UK Ltd) in 1% blocking 
solution at room temperature for 2 hours. Membranes were 
washed three times in phosphate-buffered saline, treated 
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with  Supersignal Western blotting detection reagent (MSC, 
Pierce, Rockford, IL) and exposed to x-ray film in the dark 
room. Digital images were acquired using a Canon Powershot 
7.1 MP camera.
Flow cytometry
First, 7.5 × 104 cells were plated in 35 mm2 dishes for 
24 hours, exposed to 12 µM gold nanoparticles in culture 
medium for 24 hours, trypsinized, centrifuged, and fixed 
in 70% ethanol at 4°C for one hour. Cells were resus-
pended in phosphate-buffered saline containing 50 µg/mL 
of  propidium iodide and 10 µg/mL RNase, and incubated 
at 37°C for 30 minutes. Samples were analyzed using a 
FACSCalibur flow cytometer and CELL-Quest software 
(Becton-Dickinson, BD Biosciences, Franklin Lakes, NJ). 
In total, 10,000 cells were analyzed per sample.
Measurement of reactive oxygen species
Cells were seeded into 6-well plates and allowed to adhere 
overnight before incubating with 12 µM gold nanoparticles. 
In addition, H
2
O
2
 was used at a concentration of 2.5 mM to 
act as a positive control for the formation of reactive oxygen 
species. At either 1 hour or 24 hours following treatment, 
nanoparticle-containing medium was removed and replaced 
with serum-free medium containing 5 µM 5-6-chloromethyl-
2′7′-dichlorodihydrofluorescein diacetate acetyl ester 
(2DCFDA, Molecular Probes, Invitrogen). Cells were 
incubated at 37ºC for 30 minutes, washed with phosphate-
buffered saline, and detached using cell dissociation buffer 
(Sigma, Gillingham, UK). Samples were analyzed using 
a FACSCalibur flow cytometer and CELL-Quest software 
(Becton, Dickinson and Company, Oxford, UK). 10,000 cells 
were analyzed per sample; values are expressed as the mean 
± standard error. Statistical significance was determined 
using a t-test.
Results
1.9 nm gold nanoparticle characterization
Commercially produced 1.9 nm gold nanoparticles were 
imaged by TEM to determine the size distribution for com-
parison with the manufacturer’s specification  (Figure 1). 
Four hundred particles were measured using Image J 
analysis software. On analysis, 70.3% of the particles ranged 
between 1.5 nm and 2.5 nm, with a mean particle diameter of 
2.2 ± 0.2 nm (Figure 1).
ICP-AES determination of gold 
nanoparticle uptake
Figure 2 shows the cellular uptake of gold nanoparticles 
as determined by ICP-AES. Gold nanoparticle uptake 
occurred in a dose-dependent and time-dependent manner 
with a steady increase in the number of nanoparticles per 
cell up to the 6-hour time point, and reaching a plateau at 
6 hours. Increasing the concentration of gold nanoparticles 
in the culture medium from 2.4 µM to 12 µM significantly 
increased the number of intracellular nanoparticles by 73% 
and 58% for L132 and DU145 cells, respectively, follow-
ing a 24-hour exposure. The slope of the curve during the 
first 6 hours of exposure was used to determine the rate of 
uptake. Exposure of DU145 and L132 cells to 12 µM gold 
nanoparticles resulted in comparable mean uptake rates 
of 1.4 × 107 and 1.6 × 107 gold nanoparticles per hour, 
respectively, increasing by 1.7-fold to 2.3 × 107 nanopar-
ticles per hour for MDA-MB-231 cells in agreement with 
the spectroscopy experiments. However, comparison of the 
total gold nanoparticles per cell indicates that both Du145 
and MDA-MB-231 cells endocytose comparable quanti-
ties, resulting in 1.6 × 108 and 1.3 × 108 gold nanoparticles, 
respectively, over 24 hours. Despite exhibiting a similar rate 
of uptake during the 6-hour time period, L132 cells endo-
cytosed significantly (P = 0.03) fewer gold  nanoparticles, 
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Figure 1 Transmission electron microscopic image of monodispersed 1.9 nm Aurovist™ gold nanoparticles. 
Note: Normal distribution of gold nanoparticle size variation, with a median particle size ranging between 2.0 nm and 2.5 nm.
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equating to 38% fewer total gold nanoparticles than 
DU145 cells. These differences are attributed to the higher 
rate of uptake in DU145 cells during the first hour of expo-
sure to the  nanoparticles.  Furthermore, calculation of the 
intracellular gold concentration  demonstrates an ability of 
the cell to  hyperconcentrate gold. DU145 and MDA-MB-
231 cells exposed to 12 µM (500 µg/mL of growth medium) 
accumulated intracellular gold concentrations of 8.4 mg/mL 
and 6.9 mg/mL, respectively, ie, approximately 17-fold and 
14-fold greater than the exposure concentration.
Immunogold confocal microscopy
1.4 nm Alexa Fluor 488 FluoroNanogold™ was used to 
gain an insight into the gross distribution of gold nanopar-
ticles within a cell. Figure 3A presents typical images of 
MDA-MB-231, DU145, and L132 cells following a 24-hour 
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exposure to medium containing 8 µg/mL FluoroNanogold. 
Qualitatively, the amount of fluorescence appeared to cor-
relate with the ICP-AES measurements, with MDA-MB-231 
and DU145 exhibiting higher fluorescence signals compared 
with L132 cells after a 24-hour exposure. Time course studies 
indicated cytoplasmic localization of the FluoroNanogold 
in the DU145 and MDA-MB-231 cells within one hour of 
exposure, with no fluorescent signal detectable in L132 cells 
before the 6-hour time point. In all cases, nanoparticle local-
ization appeared to be constrained to cytoplasmic regions of 
the cell with areas of high intensity. This was particularly 
evident in the two tumor cell lines, with regions of greater 
intensity observed in the perinuclear protoplasm. However, 
despite these similarities, differences in the surface coating 
of FluoroNanogold and the presence of a fluorophore may 
significantly alter the intracellular distribution, necessitating 
comprehensive TEM study.
TEM and energy dispersive x-ray 
spectroscopy
TEM was used to determine the intracellular distribution of 
1.9 nm gold nanoparticles following a 24-hour exposure at 
12 µM. Figure 3B (panels 1–3) is representative of typical 
conventional TEM micrographs obtained using a Phillips 
CM 100 TEM at 100 kV. MDA-MB-231 and DU145 cells 
exhibited large secondary lysosomal structures packed with 
aggregates of a highly electron-dense material, which were 
confirmed to be gold aggregates using energy dispersive x-ray 
spectroscopy (Figure 3D). In keeping with the published lit-
erature, these gold nanoparticle lysosomes were constrained 
to the cytoplasm (Figure 3B). Evidence corroborating the 
observed difference in gold nanoparticle uptake by L132 cells 
was also observed by TEM. The characteristic large second-
ary lysosomal structures noted in the MDA-MB-231 and 
DU145 cells were much less densely packed, suggesting that 
L132 cells exhibit reduced endocytotic capacity. As with the 
MDA-MB-231 and DU145 tumor cells, no localization with 
other cytoplasmic organelles or the nuclear membrane was 
observed. High resolution images of MDA-MB-231 cells 
were obtained using the FEI Technai F20 TEM field emission 
transmission electron microscope (Figure 3C). To improve 
image quality and limit vesicle and endosome saturation, cells 
were exposed to 2.4 µM of 1.9 nm gold nanoparticles for a 
maximum of 6 hours. As with conventional TEM, secondary 
lysosomal bodies were observed 6 hours following exposure, 
and exhibiting typical aggregates (Figure 3C, panel 1). 
 However, we also found evidence of nonendosomal intracel-
lular gold nanoparticle distribution. Areas of comparatively 
diffuse, high electron-dense material were observed  coating 
the outer membrane of an invaginated clathrin pit, with 
several intracytoplasmic vesicles appearing to demonstrate 
gold nanoparticles associated with their outer membrane 
(Figure 3C, panel 2). Interestingly, we also observed some 
of this material localized within the nucleus, exhibiting 
an apparent preference for heterochromatin accumulation. 
However, due to the relatively low nuclear concentrations 
compared with the dense endosome aggregations and the 
sensitivity limitations of energy dispersive x-ray spectroscopy 
analysis, we could not achieve a positive gold signal 
confirming the presence of gold nanoparticles distributed 
within the nucleus (Figure 3C, panel 4).
Cell growth assay
Cell growth curves were used to determine the effect of 
12 µM 1.9 nm gold nanoparticles on cytokinesis (Figure 4A). 
Total cell numbers were fitted to an exponential growth equa-
tion, from which cell doubling time and the 95% confidence 
interval (CI) were calculated. A significant (P = 0.0007) 
retardation of cell growth was observed in the MDA-MB-
231 cells 72 hours after gold nanoparticle exposure, with 
cell doubling time increasing from 22.7 hours (95% CI 
21–25) for control cells to 29 hours (95% CI 23–38) for 
gold nanoparticle-treated cells. No significant difference 
in cell growth rates were observed in either the DU145 or 
L132 cell lines.
MTT cell proliferation assay
The MTT assay was used to assess the effect of gold nano-
particle concentration on cell viability in the same three cell 
lines as shown in Figure 4A. A dose-dependent reduction 
in cell viability was observed in DU145 and MDA-MB-231 
cell lines, with LD
50
 values of 838 ± 11 µg/mL (20 µM) and 
1028 ± 11 µg/mL (24.6 µM), respectively. L132 cells were 
much more resistant to 1.9 nm gold nanoparticles, with an 
extrapolated LD
50
 value of 13,300 ± 130 µg/mL (320 µM) 
(Figure 4B). The MTT assay was also used to corroborate 
cell growth curve findings following exposure to the 1.9 nm 
gold nanoparticles. All cell types were exposed to 12 µM gold 
nanoparticles for 24 hours and assayed at various time points 
up to 72 hours. MDA-MB-231 cells exhibited a significant 
(P = 0.03) reduction in viability compared with controls after 
as little as 24 hours after gold nanoparticle treatment, with 
cytostatic growth characteristics persisting out to 72 hours 
following treatment. Neither DU145 nor L132 cells exhibited 
any significant effect in relation to viability as determined 
by MTT assay.
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Clonogenic assay
Colony-forming assays were used to determine the long-term 
cytotoxic and radiosensitizing potential of 1.9 nm gold nano-
particles (Figure 4C). A significant (P = 0.01) cytotoxic effect 
was observed in MDA-MB-231 cells following a 24-hour 
exposure to 12 µM gold nanoparticles, equating to a 21% 
reduction in surviving fraction. No significant reduction in 
the colony-forming potential of DU145 or L132 cells was 
observed following exposure to gold nanoparticles. MDA-
MB-231 cells treated with 12 µM GMP were significantly 
(P = 0.002) more sensitive to 3 Gy x-ray than control cells, 
increasing the therapeutic efficacy by 87%. No significant 
enhancement of radiation sensitivity was observed in the 
DU145 or L132 cells.
Expression of proapoptotic proteins
Western blot analysis was used to determine if expo-
sure to gold nanoparticles induced expression of various 
 proapoptotic-related proteins. Procaspase-9 (47 kDa), one of the 
late apoptosis-initiating proteins of the intrinsic pathway, was 
analyzed, along with the effector PARP, a DNA repair enzyme 
commonly cleaved as a result of caspase-3 and caspase-7 
activation. In MDA-MB-231 cells (Figure 5A), a reduction in 
full length caspase-9 and PARP was observed from as early as 
30 minutes after exposure to the gold nanoparticles, extending 
for the duration of the time course. Furthermore, there was 
a corresponding increase in the 89 kDa cleaved PARP frag-
ment containing the catalytic and automodification domains. 
Likewise, in DU145 cells, but to a lesser extent, increases in 
both cleaved caspase-9 and cleaved PARP were evident after 
24 hours, indicating that this concentration of gold nanopar-
ticles was sufficient to induce an apoptotic response. After 
loading control correction, no increased cleavage of caspase-9 
or PARP was observed in L132 cells.
Flow cytometry
Propidium iodide, a fluorescent DNA intercalating agent, 
was used to stain and quantify the proportion of cells in the 
MDA-MB-231 
20 40 60 80
0
1.0 × 105
1.5 × 105
2.0 × 105
5.0 × 104
0 20 40 60 800
0
C
el
l n
u
m
b
er
C
el
l n
u
m
b
er
Control
12 µM GNP
Control
12 µM GNP
Time (h)
20 40 60 80
0
1.0 × 105
2.0 × 105
3.0 × 105
0
C
el
l n
u
m
b
er
Control
12 µM GNP
Time (h)
150000
100000
50000
Time (h)
L132DU145A
B
C
DU145
MDA
L132
120
100
80
60
40
20
0
1 2 3 4
P
er
ce
n
t 
su
rv
iv
al
Log GNP concentration (µg/mL)
Co
nt
ro
l
12
 
µM
 G
NP
3 G
y +
 12
 
µM
 G
NP3 G
y
Co
nt
ro
l
12
 
µM
 G
NP
3 G
y +
 12
 
µM
 G
NP3 G
y
Co
nt
ro
l
12
 
µM
 G
NP
3 G
y +
 12
 
µM
 G
NP3 G
y
MDA-MB-231
1.0
0.8
0.6
0.4
0.2
0.0S
u
rv
iv
in
g
 f
ra
ct
io
n **
DU145
1.0
0.8
0.6
0.4
0.2
0.0
S
u
rv
iv
in
g
 f
ra
ct
io
n
L132
1.0
0.8
0.6
0.4
0.2
0.0S
u
rv
iv
in
g
 f
ra
ct
io
n
Figure 4 Determination of gold nanoparticle-induced cell growth inhibition and cytotoxicity. (A) Cell growth curves for MDA-MB-231, DU145, and L132 cells following 
a 24-hour exposure to medium containing 12 µM gold nanoparticles. (B) MTT assay of cell viability in DU145, MDA-MB-231, and L132 cells with increasing 1.9 nm gold 
nanoparticle concentrations. L132 cells are much more resistant to gold nanoparticles than the malignant cell lines, with LD50 values calculated at 838 ± 11 (20 µM), 1028 ± 11 
(24.6 µM), and 13,300 ± 130 µg/mL (320 µM), respectively. (C) Cytotoxicity and radiosensitization potential determined by clonogenic assay following a 24-hour exposure to 
medium containing 12 µM gold nanoparticles. Irradiated cells were given a 3 Gy dose of 160 kVp x-rays. Colonies were fixed and stained after 2 weeks. Statistical significance 
was calculated using the two-tailed unpaired t-test, with a P value of #0.05 considered to be statistically significant. 
Abbreviation: GNP, gold nanoparticles.
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sub G
1
 phase of the cell cycle, indicative of nonviable cells. 
A significant (P = 0.003 and P = 0.02) increase by 2.9-fold 
and 2.0-fold in the sub G
1
 cell population of MDA-MB-132 
and DU145 cells, respectively, was observed, following a 
24-hour treatment with 12 µM gold nanoparticles. This find-
ing is in agreement with the increased expression of various 
proapoptotic proteins, and confirms that this preparation of 
gold nanoparticles induces cell death in these tumor cell 
line models. No increase, in the sub G
1
 cell population was 
observed in the L132 cell line, providing further evidence that 
1.9 nm gold nanoparticles do not induce any loss of viability 
in these immortalized normal cells.
Measurement of reactive oxygen species
We measured the relative change in generation of reactive 
oxygen species in the three cell lines following gold nano-
particle exposure to determine if the nanoparticles resulted 
in production of reactive oxygen species and if this was cor-
related with the observed cytotoxic and apoptotic  findings. 
There was a significant (P = 0.0132 and P = 0.0196) increase 
in reactive oxygen species production in both the MDA-MB-
231 and DU145 cells, respectively, one hour after treatment 
with 12 µM gold nanoparticles. Furthermore, levels of reac-
tive oxygen species remained elevated over a 24-hour period. 
In keeping with the cytotoxic and apoptotic data, treatment 
with 12 µM gold nanoparticles failed to increase generation 
of reactive oxygen species significantly in L132 immortal-
ized lung epithelial cells.
Discussion
Radiation absorption by high (Z) atomic number materials 
resulting in production of various secondary electron spe-
cies is generally credited as being the mechanism of gold 
nanoparticle radiosensitization. Therefore, the amount of 
gold nanoparticles within a given cell and the distribution 
of these particles should directly impact upon the degree 
of radiosensitization. We have demonstrated that gold 
nanoparticle uptake occurs in a concentration-, time-, and 
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cell  type-dependent manner. We report biphasic uptake 
 characteristics, with maximal uptake occurring within the 
first few hours of exposure, reaching a plateau phase after 
6 hours. This is consistent with the data reported by Chithrani 
et al,19 who postulated that serum proteins bind to the  surface 
of citrate-stabilized gold nanoparticles, producing a more 
stable gold nanoparticle-protein complex, capable of inter-
acting with cell surface receptors.19 Alterations in culture 
conditions (eg, temperature and intracellular adenosine 
triphosphate levels) significantly inhibited cellular uptake 
in that study, highlighting the energy-dependent nature of 
gold nanoparticle uptake. The precise uptake mechanism 
was elucidated using manipulation of intracellular sucrose 
and potassium levels, known to disrupt the clathrin-mediated 
endocytosis pathway.20,30
Nanoparticle size has also been shown to be closely 
associated with uptake potential, where clathrin-mediated 
endocytosis is the main entry route for particles up to 200 nm, 
after which caveolae-mediated endocytosis dominates.31 
 Current data suggest that the optimal size for clathrin-
mediated endocytosis falls between 25 nm and 50 nm, with 
a reduced uptake potential for extremely small (,10 nm) or 
extremely large (.100 nm) particles.20,32,33 Using Herceptin® 
conjugated to gold nanoparticles (Her-gold nanoparticles), 
Jiang et al34 demonstrated that 40 nm Her-gold nanopar-
ticles exhibit a higher receptor binding affinity (about three 
orders of magnitude) for cell surface receptors than do 2 nm 
 Her-gold nanoparticle complexes.34
Direct comparisons of our own data with previously pub-
lished work is complicated due to the number of variables, 
including cell type, exposure time, concentration, and particle 
size. Table 1 details the individual experimental conditions of 
various studies and compares the total number of gold atoms 
per cell and the intracellular gold concentration with the 
 current data. Despite the fact that a 1.9 nm gold nanoparticle 
contains just 213 atoms, calculations derived from our ICP-
AES results indicate that MDA-MB-231 cells endocytose 
between 5000 and 10,000 times more gold nanoparticles per 
cell compared with previously published citrate stabilized 
particles.19 Furthermore, calculations of the total number of 
gold atoms per cell indicate comparative uptake potentials, 
irrespective of size. Furthermore, the hyperconcentration of 
intracellular gold demonstrates active uptake of the particles 
to concentrations many times greater than initially exposed 
to. This has positive downstream implications in relation to 
the development of a clinically relevant particle by reduc-
ing the amount of gold nanoparticles required to achieve 
therapeutic gain. In our TEM studies, the presence of large 
endosomal aggregates, formed by the fusion of cytosolic 
vesicles with lysosomes, suggests that the majority of 1.9 nm 
particles are endocytosed in a relatively unaggregated state 
and subsequently fuse with endosomes to form the larger 
intracellular aggregates. Furthermore, consistent with the 
lower gold nanoparticle uptake potential of L132 cells, these 
endosomal aggregates were fewer and less densely packed 
than those observed in the tumor cell lines. This suggests that, 
in addition to the enhanced permeation and retention effect 
described in vivo by Maeda et al,35 tumor cells also exhibit 
a higher endocytotic capacity, though further studies using 
other cell lines, both malignant and normal, will be required 
to determine this with confidence.35,36
The potential of gold nanoparticles as radiosensitizers 
through the generation of secondary electrons is directly 
affected by intracellular localization because the distance 
from the critical cellular target (DNA) will determine the 
efficacy of the secondary electrons. Nanodosimetry model-
ing carried out by our group indicates that approximately 
90% of the secondary electron species generated from a 
Table 1 Comparison of existing uptake data for various gold nanoparticle preparations, total nanoparticles per cell, and absolute 
number of total gold atoms per cell
Study Cell type GNP diameter  
(nm)
Atoms  
per AuNP
Maximum  
GNP per cell
Au atoms  
per cell
Intracellular  
Au conc (mg/ml)
Coulter et al  
(current study)
MDA-MB-231 1.9 213 1.31E + 08 2.79E + 10 6.9
Coulter et al  
(current study)
DU145 1.9 213 1.59E + 08 3.39E + 10 8.4
Coulter et al  
(current study)
L132 1.9 213 1.15E + 08 2.4E + 10 5.9
Chithrani et al19 HeLa 14 85390 3000 2.25E + 08 0.06
Chithrani et al19 HeLa 50 3890000 6160 2.40E + 10 5.94
Chithrani et al19 HeLa 74 12610000 2988 3.77E + 10 9.33
Nativo et al39 HeLa 16 127431 3.34E + 04 4.256E + 09 1.05
Note: Statistical significance calculated using the two-tailed unpaired t-test, with a P value of #0.05 considered significant.
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10 nm gold nanoparticle are low-energy electrons (1.5 kV), 
increasing the dose deposition by 100-fold within a radius 
of less than 40 nm from the gold nanoparticle surface. The 
remaining high-energy electrons (.10 kV) account for 
approximately 10% of the secondary electrons produced, with 
a maximum range of  .10 µm.37 Endosomal entrapment of 
the gold nanoparticles within the cytosol prevents nuclear 
localization; however, various groups have attempted with 
some success to localize the gold nanoparticles within the 
nucleus, thereby increasing DNA damage and ultimately 
the formation of lethal double-strand breaks.38–41 Using field 
emission TEM, we observed the characteristic localization 
of gold nanoparticles within the endosome as previously 
described (Figure 3C, panel 1). However, we also observed 
small (,5 nm) electron-dense particles in an unaggregated 
state inside the nuclear membrane (Figure 3C, panels 3 
and 4). It should be noted that we failed to obtain a positive 
gold energy dispersive x-ray spectroscopy signature due to 
the sparse distribution of the material; however, studies of the 
nuclear pore complex indicate that small particles less than 
9 nm are capable of both entering and exiting the eukaryotic 
nucleus via the nuclear pore complex by active diffusion.42,43 
Therefore, if the material presented in Figure 3C does repre-
sent intranuclear 1.9 nm gold nanoparticles, the use of small 
gold nanoparticles (,9 nm) would negate the need to add 
an additional level of complexity of specific nuclear target-
ing in the development of a candidate gold nanoparticle for 
systemic delivery.
Reports of gold nanoparticle cytotoxicity are conflicting, 
and have been attributed to a variety of factors, including 
surface coating, nanoparticle charge, and size.21,23,24,44 Perhaps 
the strongest evidence for gold nanoparticle cytotoxicity is 
associated with particle size. Two similar gold nanoparticle 
preparations differing only in size showed very different cyto-
toxic profiles. Gold nanoparticles of size 1.4 nm capped with 
triphenylphosphine monosulfate were 100-fold more toxic 
than a 15 nm nanoparticle comprising identical components.45 
Conversely, Hondroulis et al46 assessed the cytotoxicity of 
a 10 nm and a 100 nm gold nanoparticle using an electrical 
impedance whole cell assay. In this instance, the authors 
failed to observe any difference in the growth potential 
between gold nanoparticle-treated cells and control cells.46 
Our findings corroborate much of the existing literature, in 
that an oversimplified conclusion, such as gold nanoparticles 
are either nontoxic or cytotoxic, fails to account for a variety 
of subtle yet important factors. We consistently demonstrated 
significant impaired growth characteristics, a reduction in cell 
viability, and a loss of clonogenicity in MDA-MB-231 cells 
following exposure to 12 µM 1.9 nm gold nanoparticles for 
a 24-hour period. However, immortalized normal L132 cells 
failed to exhibit any notable cytotoxicity. Although likely to 
be a contributing factor, different uptake potentials should 
not be solely attributed to cytotoxicity, because the total gold 
concentration per DU145 cell is greater than that of an MDA-
MB-231 cell, and although uptake was lower, L132 cells 
consistently internalize approximately 60% of the maximum 
number of gold nanoparticles endocytosed by a DU145 cell. 
Interestingly, the correlation between maximum uptake and 
potential radiosensitization did not directly relate to the dif-
ferential uptake potential, with MBA-MB-231 cells being 
the only cell line model investigated exhibiting significant 
gold nanoparticle-induced radiosensitization.
We examined expression levels of various proteins asso-
ciated with apoptosis to establish if 1.9 nm gold nanoparticles 
promoted cell death via this pathway. An increase in both 
cleaved caspase-9 and cleaved PARP was observed in MDA-
MB-231 and DU145 cells, correlating with a reduction in 
cell growth and clonogenicity. Furthermore, no detectable 
upregulation of these proteins was detected in L132 cells. 
Analysis of the sub G
1
 cell population further corroborated 
the Western blot findings, indicating that apoptosis was the 
likely mode of cell death. As with other aspects of gold 
nanoparticle research, variables in experimental design often 
result in contrasting conclusions. A recent study by Kang 
et al41 demonstrated significant cytotoxicity of 30 nm gold 
nanoparticles conjugated with a nuclear localization signal, 
resulting in increased γ-H2aX phosphorylation (a surrogate 
marker of DNA double-strand breaks) and an accumulation 
of cells in the sub G
1
 phase of the cell cycle. The authors 
concluded that gold nanoparticle nuclear localization resulted 
in arrest of cytokinesis, with an increased apoptotic cell popu-
lation following exposure to gold nanoparticles.41 However, 
in another study, pretreatment of cells with Z-VAD-fmk, a 
caspase inhibitor, failed to rescue cells following exposure 
to a high concentration (96 µM, 2 × LD
50
) of a 1.4 nm gold 
nanoparticle preparation, suggesting that necrosis, and not 
apoptosis, was the predominant pathway at this  concentration. 
Addition of the antioxidants, N-acetylcysteine and glutathi-
one, abrogated the effect, leading the authors to conclude that 
gold nanoparticles at high concentrations cause oxidative 
stress via increased production of endogenous reactive oxy-
gen species and depletion of intracellular antioxidants.45 We 
directly measured reactive oxygen species production using 
2DCFDA, and observed an increase in MDA-MB-231 and 
DU145 cells which correlated with increased cytotoxicity and 
all of the apoptotic endpoints investigated. Despite the lack of 
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a significant increase in generation of reactive oxygen species 
in L132 cells, the consistent trend towards elevated reactive 
oxygen species indicates a role for the induction of gold 
nanoparticle-induced oxidative stress, with our tumor cell 
models indicating a higher degree of sensitivity to oxidative 
damage. This biological phenomenon adds further credence 
to the findings by Jain et al17 who described radiosensitization 
using gold nanoparticles at MV energies and suggested that, 
in addition to the physical process of radiosensitization, due 
to the differences in the absorption coefficient between gold 
and soft tissue, there may be additional biological effects 
responsible for radiosensitization.17
In conclusion, there is clear variability between the uptake 
potential of the cell lines investigated. While it is interesting 
that the immortalized normal cell line did not endocytose 
gold nanoparticles as efficiently as the tumor cell lines, 
studies in a much broader range of cells will be needed to 
determine if there is a consistent difference. Strong evidence 
for biological sensitization is provided by the localization of 
gold nanoparticles within the cytoplasm, thereby limiting 
the DNA-damaging capabilities of low energy secondary 
electrons. This is further substantiated by our previous find-
ings that gold nanoparticles induced no significant increase 
in double-strand break formation, and bleomycin, a radio-
mimetic agent, in the presence of 12 µM gold nanoparticles, 
resulted in a sensitizer enhancement ratio of 1.38.17 Although 
significant cytotoxicity was observed in MDA-MB-231 cells, 
resulting in a 21% reduction in clonogenicity, cytotoxicity 
in the remaining cell lines was less than 10%. We believe 
that the cytotoxicity observed does not limit the usefulness 
of this gold nanoparticle preparation as a potential sensitiz-
ing modality, because current radiosensitizing agents, such 
as cisplatin and cetuximab, exhibit much greater levels of 
normal cell damage.47,48
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